NEW YORK--(BUSINESS WIRE)--Lescarden, Inc. (LCAR:OB) announced today that it had entered into a distribution agreement with Cranage Healthcare Ltd. to market Lescarden’s proprietary CATRIX® WOUND DRESSING in the United Kingdom and Ireland. Regulatory marketing approvals and product reimbursement arrangements are being secured, and it is anticipated that product launch will commence in the first quarter of 2009.
